FI763215A7 - - Google Patents

Download PDF

Info

Publication number
FI763215A7
FI763215A7 FI763215A FI763215A FI763215A7 FI 763215 A7 FI763215 A7 FI 763215A7 FI 763215 A FI763215 A FI 763215A FI 763215 A FI763215 A FI 763215A FI 763215 A7 FI763215 A7 FI 763215A7
Authority
FI
Finland
Application number
FI763215A
Other languages
Finnish (fi)
Inventor
Ulrich Gebert
Josef Musil
Rolf-Ortwin Weber
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI763215A7 publication Critical patent/FI763215A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI763215A 1975-11-13 1976-11-10 FI763215A7 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2550959A DE2550959C3 (de) 1975-11-13 1975-11-13 Tetrazolyl-imidazole und Tetrazolyl--benzimidazole, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
FI763215A7 true FI763215A7 (fr) 1977-05-14

Family

ID=5961645

Family Applications (1)

Application Number Title Priority Date Filing Date
FI763215A FI763215A7 (fr) 1975-11-13 1976-11-10

Country Status (21)

Country Link
US (1) US4152440A (fr)
JP (3) JPS5262278A (fr)
AT (1) AT357155B (fr)
AU (1) AU504009B2 (fr)
BE (1) BE848280A (fr)
CA (1) CA1097350A (fr)
DE (1) DE2550959C3 (fr)
DK (1) DK511376A (fr)
ES (1) ES453276A1 (fr)
FI (1) FI763215A7 (fr)
FR (1) FR2363328A1 (fr)
GB (1) GB1545939A (fr)
GR (1) GR70648B (fr)
HU (1) HU173879B (fr)
IE (1) IE44184B1 (fr)
IL (1) IL50892A (fr)
LU (1) LU76188A1 (fr)
NL (1) NL7612610A (fr)
NO (1) NO763876L (fr)
SE (1) SE7612685L (fr)
ZA (1) ZA766715B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071866A (en) * 1989-07-31 1991-12-10 Bristol-Myers Squibb Company Arylpyrazole derivatives as anti-platelet agents
JP4836280B2 (ja) * 2004-06-18 2011-12-14 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 癌を治療するためのキネシンスピンドルタンパク質（ｋｓｐ）阻害剤としてのｎ−（１−（１−ベンジル−４−フェニル−１ｈ−イミダゾール−２−イル）−２，２−ジメチルプロピル）ベンズアミド誘導体および関連化合物
JP2010515687A (ja) * 2007-01-05 2010-05-13 ノバルティス アーゲー キネシンスピンドルタンパク質阻害剤（ｅｇ−５）としてのイミダゾール誘導体
WO2008153129A1 (fr) * 2007-06-14 2008-12-18 Teijin Pharma Limited Agent pour abaisser le taux d'acide urique
PE20110368A1 (es) * 2008-08-18 2011-06-13 Univ Yale Moduladores de mif
US9540322B2 (en) 2008-08-18 2017-01-10 Yale University MIF modulators
EP2508511A1 (fr) 2011-04-07 2012-10-10 Laboratoire Biodim Inhibiteurs de la réplication virale, leur procédé de préparation et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2470085A (en) * 1947-03-07 1949-05-17 Bilhuber Inc E Substituted amino alkyl tetrazoles
BE535047A (fr) * 1954-01-21
US3935209A (en) * 1973-03-12 1976-01-27 Syntex (U.S.A.) Inc. 5(6)-Benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
SE7408483L (fr) * 1973-07-27 1975-01-28 Ciba Geigy Ag
DE2362171A1 (de) * 1973-12-14 1975-06-26 Hoechst Ag (1-alkyl-5-nitro-imidazolyl-2-alkyl)heteroaryl-verbindungen und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
GB1545939A (en) 1979-05-16
LU76188A1 (fr) 1977-06-06
DK511376A (da) 1977-05-14
CA1097350A (fr) 1981-03-10
JPS5547677A (en) 1980-04-04
IE44184L (en) 1977-05-13
AU504009B2 (en) 1979-09-27
NL7612610A (nl) 1977-05-17
FR2363328A1 (fr) 1978-03-31
JPS5262278A (en) 1977-05-23
DE2550959B2 (de) 1980-04-10
DE2550959C3 (de) 1980-12-04
GR70648B (fr) 1982-12-03
ES453276A1 (es) 1978-02-01
HU173879B (hu) 1979-09-28
ATA844476A (de) 1979-11-15
DE2550959A1 (de) 1977-05-26
IL50892A (en) 1981-02-27
FR2363328B1 (fr) 1979-08-31
IL50892A0 (en) 1977-01-31
JPS54163578A (en) 1979-12-26
AU1952576A (en) 1978-05-18
ZA766715B (en) 1977-10-26
NO763876L (fr) 1977-05-16
JPS5531155B2 (fr) 1980-08-15
AT357155B (de) 1980-06-25
SE7612685L (sv) 1977-05-14
US4152440A (en) 1979-05-01
BE848280A (fr) 1977-05-12
IE44184B1 (en) 1981-09-09

Similar Documents

Publication Publication Date Title
FR2312808B1 (fr)
FR2363328B1 (fr)
JPS5419090B2 (fr)
JPS5339260B2 (fr)
JPS51118332U (fr)
JPS5217877U (fr)
FI763703A7 (fr)
AR204567A1 (fr)
JPS51149418U (fr)
JPS5257977U (fr)
CS169696B1 (fr)
JPS5269655U (fr)
JPS5268766U (fr)
JPS51126721U (fr)
CH610784A5 (fr)
CH584583A5 (fr)
CH599497A5 (fr)
CH590634A5 (fr)
CH613161A5 (fr)
CH582333A5 (fr)
CH607291A5 (fr)
CH588401A5 (fr)
BG22504A1 (fr)
CH597501A5 (fr)
CH604187A5 (fr)

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: HOECHST AG